Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Koneksa logo — Koneksa is a leading patient-centric digital biomarker compa...

Koneksa

Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries.

Founded 2015 United States New York, United States 81 employees Grant Total: $70.65M Analytics, Big Data +2

General Information

Company Name Koneksa
Founded Year 2015
Location United States New York, United States
Employees 81
Industries Analytics, Big Data, Health Care +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Koneksa. To contact Koneksa, visit koneksahealth.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Koneksa compare?

A PDF of Koneksa and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Koneksa soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Koneksa

Koneksa is a patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Founded in 2015 and headquartered in the United States, Koneksa supports agile decision-making in drug development and market strategy. The company aims to revolutionize effect detection in clinical research by delivering integrated solutions for efficient trial designs that produce more meaningful data. The latest investment, a grant investment, was received on 08 August 2022 from the Michael J. Fox Foundation. Specialized in Analytics, Big Data, Health Care, and Information Technology, Koneksa is indeed a pivotal player in leveraging digital technology to enhance patient care and clinical research.

Business keywords: digital biomarker, clinical data collection, drug development, pharmaceutical industry, remote monitoring, patient-centric solutions, trial design, efficacy detection

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research
08 Aug 2022
Grant Undisclosed 1
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research
16 Jun 2022
Series C $45.00M 8
dRx Capital McKesson Ventures Takeda Pharma
dRx Capital, McKesson Ventures +6
07 Feb 2022
Series B $16.00M 7
dRx Capital MBX Capital McKesson Ventures
dRx Capital, MBX Capital +5
28 Sep 2020
Venture Round $9.65M -
25 Mar 2020
Venture Round Undisclosed 1
Merck Global Health Innovation Fund
05 May 2015

Koneksa Alternatives & Competitors

View All Alternatives
Koneksa vs
Novozen Healthcare LLC
Novozen Healthcare LLC United States

We are an emerging company, which provides Staffing services to the Pharmaceutical and Healthcare IT...

52 employees
Blockchain, Cyber Security
Compare Koneksa vs Novozen Healthcare LLC
Koneksa vs
HuCare
HuCare Italy

Il clinical trial management system facile da usare, anche per il paziente

Pre-Seed
6 employees
Health Care, Information Technology
Compare Koneksa vs HuCare
Koneksa vs
Cognivia
Cognivia Belgium

Developing predictive tools to de-risk clinical drug development

Venture round
26 employees
Biotechnology, Health Care
View all alternatives

FAQ About Koneksa

Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries.
Koneksa was founded in 2015.
Koneksa is headquartered in New York, United States.
Koneksa operates in Analytics, Big Data, Health Care and Information Technology. Its work centres on digital biomarker, clinical data collection, drug development and pharmaceutical industry.
Koneksa has approximately 81 employees.
Koneksa has completed 6 funding rounds, raising a total of $70.65M. The latest funding stage is Grant.
Top alternatives and competitors to Koneksa include Novozen Healthcare LLC, HuCare, Cognivia, AiCure, Innovation Sprint. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Koneksa and Novozen Healthcare LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Koneksa, https://bouncewatch.com/company/koneksa, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes